webinar register page

Webinar banner
MS Academy - Early-effective treatment:
This webinar has received sponsorship from Novartis Pharmaceuticals UK limited. The first session in the webinar is designed and delivered by the MS Academy and sponsored by Novartis Pharmaceuticals UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a satellite symposium that is organised and funded by Novartis Pharmaceuticals UK limited.

12:00 - 12:45 - Case study discussion: Early-effective treatment

Chair: Prof Gavin Giovannoni
Speakers: Prof Neil Robertson & Rachel Dorsey-Campbell

12:45 - 12:50 - Break


12:50 - 13:30: Satellite Symposium - Novartis Pharmaceuticals UK limited - When & how to switch eligible patients to MAYZENT▼ (siponimod) – Real World Experience

Chair: Prof Gavin Giovannoni
Speaker: Prof Christoph Kleinschnitz

Please join us to hear Prof Christoph Kleinschnitz share his experience in switching patients to MAYZENT.

UK | April 2021 | 120951

Prescribing information for MAYZENT▼ (siponimod) and adverse event reporting details can be found here: https://www.health.novartis.co.uk/sites/health.novartis.co.uk/files/mayzent-pi.pdf

For information about how we use your data, visit https://neurologyacademy.org/privacy-policy

May 10, 2021 12:00 PM in London

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.